One S. aureus plasmid coding for tetracycline resistance, pT127, and four plasmids (pC194, pC221, pC223, and pUB112) coding for chloramphenic resistance have been introduced by transformation into B. subtifis. The plasmids replicate in-and confer antibiotic resistance upon-their new host. These experiments show that the potential for genetic exchange between diverse bacterial species is greater than has been commonly assumed.
MATERIALS AND METHODS
Bacterial Strains. S. aureus strains used were SA231 (pC194) Cmr, RN154 (pC223) Cmr, RN1305 (pC221) Cmr, RN1777 (pS177) Smr, RN1801 (pT127) Tcr, RN1953 (pK545) Kmr/ Nmr, and RN2438 (pUB112) Cmr from R. Novick (2) . B. subtills strains SB634 thy-aroB tyr-1 and SB748 his-2 trypC2 thy-, derived from SB168, are from the Stanford collection.
Media. B. subtilis was grown in L and Penassay liquid media. Resistant bacteria were selected on L-agar plates supplemented with antibiotics [tetracycline (Tc), 15 ,ug/ml; chloramphenical (Cm), 5 ,ug/ml; streptomycin (Sm), 30 jig/ml; kanamycin (Km), 3 jig/ml] S. aureus cells were grown in CY liquid media or on GL-agar plates (3) . DNAs and Enzymes. Plasmid DNAs were prepared from S. aureus strains essentially as described by Novick (2) . Low-salt lysates of stationary phase cultures were clarified by centrifugation, concentrated with polyethylene glycol (molecular weight; 6000), and centrifuged to equilibrium in CsCl density gradients containing ethidium bromide. Cleared lysis treatment of B. subtilis strains was essentially as described for E. coli (4) . Lysates were then processed similarly to the S. aureus ones (see above).
EcoRI endonuclease and T4 ligase were purified and used as described (5, 6) . HindIII was a commercial preparation (BioLabs).
Transformation Procedure. Induction of competence and transformation of B. subtilis were as described (7) .
Electrophoresis and Electron Microscopy. Horizontal agarose slab gels were used as described (8) . Electron microscopy was also performed (9) .
RESULTS
Tetracycline resistance plasmid pT127 S. aureus strain RN1801 carries the plasmid pT127 that confers tetracycline resistance on its host (3). The plasmic DNA can transform B. subtilis strains to tetracycline resistance: 107 cells of SB634 (competence level 0.2%) exposed to 0.1 Ag of pT127 DNA yielded 10 Tcr colonies. No colonies were observed if either the cells or the DNA was omitted. The typical appearance and phenotypic match of the SB634 parent strain, auxotrophic thy-aroB-tyr-, to the Tcr colonies confirmed that the colonies were B. subtilis.
The level of resistance of the transformants was higher than 25 ,ug/ml in L-broth, although at concentrations above 15 ,ug/ml some inhibition of growth could be seen. The parental B. subtilis strain is inhibited by 5 ,g/ml of Tc. Resistance was found to be a stable trait: growth for some 20 generations in liquid medium devoid of antibiotic, followed by plating on the solid medium of the same type, resulted in less than 2% observed colonies sensitive to tetracycline, as revealed by replica-plating on medium supplemented with the drug.
One of the Tcr colonies was chosen for further study. A profile of the cesium chloride/ethidium bromide density gradient for its cleared lysis supematant is displayed in Fig. 1 . Two peaks of radioactivity can be seen. Identically treated-parental Tcs cells yielded only the lower density peak ( Fig. 1 ) composed of linear DNA molecules.
The heavier peak, detected in the extract of Tcr transformants, contains supercoiled circular DNA molecules, as revealed by electron microscopy. These match the pT127 DNA molecules extracted from S. aureus, by the following criteria: (i) the two intact circular DNA preparations have identical electrophoretic mobilities; (ii) they are both resistant to EcoRI endonuclease and are cleaved by the HindIII nuclease into three matching segments. These data are displayed in Fig. 2 .
Equivalence of the two DNA preparations was verified by further genetic tests: two B. subtilis strains, SB634 and SB748, were transformed to tetracycline resistance with the DNA isolated from the Tcr Bacillus colonies, as well as with the pT127 DNA isolated from S. aureus.
Chloramphenicol resistance plasmids Four S. aureus Cmr plasmids (pC194, pC221, pC223, and pUB112) were tested for their ability to transform B. subtilis to chloramphenicol resistance. The results were similar to those described for the Tcr plasmid, above. (1977) these experiments only a small fraction of the DNA b aken up.) The efficiency increased some 50 times, approaching the level of 10-7 colonies per genome equivalent (104 colonies per ,ug of DNA) with plasmids isolated from transformed B. subtilis cells. Less than 0.5% of the efficiency remained after cleavage of plasmid DNAs with the HindIII restriction endonuclease. Treatment of cleaved DNAs with T4 ligase, resulting in about 50% recircularization (as revealed by electron microscopy inspection), restored 30-50% of the original efficiency for Cmr plasmids, and less than 0.2% for the Tcr one.
DISCUSSION
The experiments reported here indicate that (i) B. subtilis strains can be transformed to antibiotic resistance with S. aureus plasmid DNAs; (ii) the transformants acquire plasmid DNA; (iii) this DNA is indistinguishable from the S. aureus plasmid DNA by criteria of size, restriction enzyme pattern, and genetic information. This evidence shows that S. aureus plasmids can replicate and be expressed in B. subtilis.
The five S. aureus plasmids introduced in B. subtilis can be subdivided into three groups: Tcr (pT127), Cmr small (pC194) and Cmr large (pC221, pC223, and pUB112, Table 1 ). Data reported by Novick (3) indicate that the three plasmids of the last group are not identical: they respond differently to various treatments which induce relaxation of supercoiled plasmidprotein complexes. It appears therefore that at least five different S. aureus plasmids can be maintained in B. subtilis.
The efficiency of interspecies transformation described here is high enough to allow the process to be demonstrated easily in the laboratory by employing competent cells and plasmid DNA.
HindIII restriction endonuclease cleavage of the plasmids decreases their biological activity to < 0.5%. This might be due to the possible presence of the restriction site within the gene coding for the antibiotic resistance and/or to the destruction of the circular structure of the plasmids necessary for their replication in the host. Another plasmid, pFT23, a hybrid between the pSC101 replicon and the thy gene of the B. subtilis phage Phi-3-T, did not lose any transforming efficiency when made linear by the action of Bam endonuclease (5) . In that case, circular structure was not obligatory because the transforming thy gene could be integrated into another replicating structure: the chromosome of the host. Ligation of the cleaved Cmr plasmids almost fully restored their biological activity, whereas the Tcr plasmid was not reactivated, presumably because of a lower probability of correct reassembly of the three HindIII segments.
S. aureus plasmids introduced into B. subtilis are promising vectors for cloning in this new host because of their small size, easily selectable markers, and a small number of cleavage sites for certain restriction enzymes.
The demonstration that replicating plasmids are shared among species of bacteria as widely diverse as Staphylococcus and Bacillus, or Escherichia and Agrobacterium [P. aeruginosa plasmid RP4, (1)] makes it likely that plasmid sharing occurs commonly in nature. This is pertinent to our views of natural microbial evolution and, in turn, to the uniqueness of constructing DNA recombinants in the laboratory, which is a premise of much policy discussion.
